Literature DB >> 32804122

Global burden of COVID-19: Situational analyis and review.

Addis Adera Gebru1,2,3, Tadesse Birhanu4, Eshetu Wendimu5, Agumas Fentahun Ayalew6, Selamawit Mulat7, Hussen Zakir Abasimel8, Ali Kazemi9, Bosenu Abera Tadesse10, Beniam Adera Gebru11, Berhanu Senbeta Deriba12, Nigus Shimelis Zeleke13, Abebe Gule Girma4, Bulgantsetseg Munkhbat4, Qamar Kassim Yusuf14, Amana Ogeto Luke2, Dejene Hailu15.   

Abstract

BACKGROUND: The novel Coronavirus Diseases 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of global community due to this disease is dramatically increasing from time to time.
OBJECTIVE: This situational analysis is aimed to analysis prevalence, and incidence of COVID-19 and to provide clear information about this disease for the scientific community, stakeholders and healthcare practitioners and decision-makers.
METHODS: The literatures were identified by searching the key relevant and officially known online databases: medRxiv, Google scholar and PubMed. The online databases contain archives of most English biomedical journals and scientific papers published online from 31 December to 3 April 2020 were included. After the literature search, articles were screened independently by two reviewers for eligibility.
RESULTS: The world continents have confirmed a total of 1,202,320 confirmed COVID-19 cases: (51.2%) in Europe, (27.7%) in North America, (17.9%) in Asia, (1.96%) in South America and at less number of confirmed COVID-19 cases in Africa and Australia which was accounted 0.8% and 0.5%, respectively. However, this review showed that there was significantly increased the confirmed COVID-19 cases by 109,555 in Asia, 8,658 in Africa, 332,866 in North America, 20,269 in South America, 568,894 in Europe, 5,051 in Australia and 1,045,403 in the whole world continent except Antarctica during the review period. The overall results showed that there were 1,098,762 cases and 59,172 deaths have recorded during the review period. The result zero number of deaths with COVID-19 was observed in 66 countries.

Entities:  

Year:  2020        PMID: 32804122     DOI: 10.3233/HAB-200420

Source DB:  PubMed          Journal:  Hum Antibodies        ISSN: 1093-2607


  16 in total

1.  Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.

Authors:  Walid Al-Qerem; Anan Jarab; Alaa Hammad; Alaa Hussein Alsajri; Shadan Waleed Al-Hishma; Jonathan Ling; Asal Saad Alabdullah; Ali Salama; Rami Mosleh
Journal:  Patient Prefer Adherence       Date:  2022-06-23       Impact factor: 2.314

2.  Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study.

Authors:  Getaneh Atikilt Yemata; Aragaw Tesfaw; Gashaw Mihret; Mulu Tiruneh; Zebader Walle; Eshetie Molla; Ermias Sisay; Fitalew Tadele Admassu; Eyaya Habtie; Tsion Desalagn; Habtamu Shimels; Fentaw Teshome
Journal:  J Multidiscip Healthc       Date:  2022-05-23

3.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

4.  Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study.

Authors:  Tesfaye Yadete; Kavita Batra; Dale M Netski; Sabrina Antonio; Michael J Patros; Johan C Bester
Journal:  Vaccines (Basel)       Date:  2021-12-02

5.  Mental Health Interest and Its Prediction during the COVID-19 Pandemic Using Google Trends.

Authors:  Magdalena Sycińska-Dziarnowska; Liliana Szyszka-Sommerfeld; Karolina Kłoda; Michele Simeone; Krzysztof Woźniak; Gianrico Spagnuolo
Journal:  Int J Environ Res Public Health       Date:  2021-11-24       Impact factor: 3.390

6.  Development of a scoring system for the prediction of in-hospital mortality among COVID-19 patients.

Authors:  Mohammad Haji Aghajani; Mohammad Sistanizad; Asma Pourhoseingholi; Ziba Asadpoordezaki; Niloufar Taherpour
Journal:  Clin Epidemiol Glob Health       Date:  2021-10-06

Review 7.  Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review.

Authors:  Nhu Ngoc Nguyen; Van Thuan Hoang; Thi Loi Dao; Pierre Dudouet; Carole Eldin; Philippe Gautret
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-02-10       Impact factor: 5.103

8.  Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.

Authors:  Behnood Bikdeli; David Jiménez; Pablo Demelo-Rodriguez; Francisco Galeano-Valle; José Antonio Porras; Raquel Barba; Cihan Ay; Radovan Malý; Andrei Braester; Egidio Imbalzano; Vladimir Rosa; Ramón Lecumberri; Carmine Siniscalchi; Ángeles Fidalgo; Salvador Ortiz; Manuel Monreal
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

9.  Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results.

Authors:  Panagiotis Mallis; Theofanis Chatzistamatiou; Zetta Dimou; Eirini-Faidra Sarri; Eleni Georgiou; Maria Salagianni; Vasiliki Triantafyllia; Evangelos Andreakos; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos
Journal:  World J Biol Chem       Date:  2022-03-27

10.  Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants.

Authors:  Chutima Seree-Aphinan; Kumutnart Chanprapaph; Ploysyne Rattanakaemakorn; Chavachol Setthaudom; Thanitta Suangtamai; Cherrin Pomsoong; Yanisa Ratanapokasatit; Poonkiat Suchonwanit
Journal:  Front Med (Lausanne)       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.